Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
insulin
MedTech
Sequel, Arecor to explore ultraconcentrated insulin delivery
Sequel will work with Arecor to develop AT278, which packs 500 units to the milliliter—about five times as much as the most common insulins today.
Conor Hale
Sep 25, 2025 1:00pm
Lilly posts more positive data on once-weekly insulin prospect
Sep 11, 2024 2:05pm
Lilly posts more positive data on its weekly insulin prospect
Sep 5, 2024 6:45am
Lilly’s weekly insulin hits primary endpoint in 2 pivotal trials
May 16, 2024 6:45am
Eli Lilly charts 2nd space trip with Redwire
Mar 12, 2024 9:44am
ADA: Dexcom plots 2024 launch of sensor for non-insulin users
Jun 27, 2023 1:27pm
